NCT03460223View on ClinicalTrials.gov

Safety and Efficacy Study of Mesenchymal Stem Cell in Treating Kidney Fibrosis

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

September 1, 2020

Conditions
Renal Cirrhosis
Interventions
BIOLOGICAL

MSC

conventional plus MSC or placebo treatment

Sponsors
All Listed Sponsors
lead

Nanjing Medical University

OTHER